Aviva Strategies (FKA MGB Consulting)

Aviva Strategies (FKA MGB Consulting) filed a Q2 report for Beam Therapeutics on July 16, 2025.

Lobbying for Beam Therapeutics · Biotechnology & drug development

As filed: AVIVA STRATEGIES (FKA MGB CONSULTING) for BEAM THERAPEUTICS.

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 16, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Lobbying activity 1

-cell and gene therapy policy

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.